Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...

A long-awaited study shows that screening for breast cancer with annual mammograms may not always be the best way to catch ...

WISDOM is an ongoing, pragmatic randomized breast cancer screening trial that included 28,372 women ages 40 to 74 years (mean ...

Lumpectomy has been the standard of care for low-risk, early-stage breast cancer, but now cryoablation — freezing cancer ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...

Overall, tucatinib add-on to first-line maintenance therapy for HER2-positive metastatic breast cancer delayed progression by ...

Cancer survivorship goes past treatment to focus on rebuilding strength, protecting function, and preventing complications ...

The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...

Patients whose cancers were hormone receptor (HR) negative – that is, their tumor cells did not have proteins that bind to ...

A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an ...

Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple ...

Real and sham acupuncture were more effective at improving breast cancer survivors' perceived cognitive impairment compared ...